Use of polyadenosine tail mimetics to enhance mRNA expression from genes associated with haploinsufficiency disorders

Bahareh Torkzaban1, Yining Zhu2,3, Christian Lopez1

  • 1Department of Molecular Biology and Genetics, Johns Hopkins University, Baltimore, MD 21205, USA.

PubMed

Insights

Researchers developed mRNA boosters that enhance gene expression by mimicking poly(A) tails. This technology shows promise for treating haploinsufficiency disorders by increasing protein production from targeted genes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Polyadenosine (poly(A)) tails on messenger RNA (mRNA) are vital for stability and translation.
  • Controlled removal of poly(A) tails in the cytoplasm regulates gene expression and can lead to mRNA degradation.
  • Haploinsufficiency disorders arise from reduced gene expression, impacting cellular function.

Purpose of the Study:

  • To develop a novel therapeutic strategy to enhance mRNA expression.
  • To investigate the potential of poly(A) tail mimetics for treating genetic disorders.
  • To demonstrate the efficacy of mRNA boosters in enhancing gene expression.

Main Methods:

  • Designing and synthesizing short RNA sequences with poly(A) tail mimetics.
  • Antisense hybridization to the 3' untranslated region (UTR) of target mRNAs.
  • In vitro and in vivo validation of enhanced mRNA expression in cell cultures and animal models.

Main Results:

  • Selective and significant enhancement of target mRNA expression was achieved using poly(A) tail mimetics.
  • The technology, termed mRNA boosters, effectively increased expression of genes linked to autism spectrum disorders (e.g., SYNGAP1, MECP2, PURA, CTNNB1).
  • Increased gene expression was observed in both human cell cultures and animal models.

Conclusions:

  • Small poly(A) tail mimetics can substantially enhance mRNA expression.
  • mRNA boosters represent a promising therapeutic modality for haploinsufficiency disorders.
  • This approach offers a potential strategy for treating genetic conditions characterized by insufficient gene dosage.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
mRNA Stability and Gene Expression02:51

mRNA Stability and Gene Expression

The structure and stability of mRNA molecules regulates gene expression, as mRNAs are a key step in the pathway from gene to protein. In eukaryotes, the half-life of mRNA varies from a few minutes up to several days. mRNA stability is essential in growth and development. The absence of the proteins regulating its stability, such as tristetraprolin in mice, can cause systemic issues, including bone marrow overgrowth, inflammation, and autoimmunity.
Cis-acting Elements involved in mRNA stability
5.5K
RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.9K
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
10.4K
Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
14.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.9K